Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F9LO
|
||||
Former ID |
DNC014013
|
||||
Drug Name |
1-(4-chlorooxazol-2-yl)-7-phenylheptan-1-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529603] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H18ClNO2
|
||||
Canonical SMILES |
C1=CC=C(C=C1)CCCCCCC(=O)C2=NC(=CO2)Cl
|
||||
InChI |
1S/C16H18ClNO2/c17-15-12-20-16(18-15)14(19)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2
|
||||
InChIKey |
HEJGWGQTJYVGGY-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529603] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.